General Information of the Compound
| Compound ID |
CP0633428
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
SID56463106
Show/Hide
|
||||||||||||||||||
| Synonyms |
(-)-Cytisine
(1R,5S)-3,4,5,6-Tetrahydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-8(2H)-one
(1r,5s)-1,2,3,4,5,6-Hexahydro-8h-1,5-Methanopyrido[1,2-A][1,5]diazocin-8-One
485-35-8
53S5U404NU
BRN 0083882
Baphitoxine
Baptitoxin
Baptitoxine
CHEBI:4055
CHEMBL497939
CYTISINE
Citizin
Cystisine
Cytisin
Cytisine (-)
Cytisine, 98%
Cytiton
Cytitone
Cytizin
EINECS 207-616-0
HSDB 3560
Laburnin
NSC 407282
Sophorine
Tabax
Tabex
Tsitizin
UNII-53S5U404NU
Ulexin
Ulexine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H14N2O
|
||||||||||||||||||
| Molecular Weight |
190.246
|
||||||||||||||||||
| Canonical SMILES |
O=c1cccc2n1C[C@@H]1CNC[C@H]2C1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2/t8-,9+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ANJTVLIZGCUXLD-DTWKUNHWSA-N
|
||||||||||||||||||
| CAS |
3728-36-7
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound